Shirt a Phobia

Sample Page

Not to be confused with MADAM-6.

MADAM, also known as N,N-dimethyl-2-(2-amino-4-methylphenylthio)benzylamine, is a highly potent and selective serotonin reuptake inhibitor (SRI) which is used in scientific research.[1] Its affinity (Kd) for the serotonin transporter (SERT) is 60 pM (0.06 nM).[1] Radiolabeled isotopologues of MADAM have been developed and used as radiotracers in positron emission tomography (PET) imaging.[2][3][4][5] The drug was first described in the scientific literature by 2001.[6][7]

References

  1. ^ a b Chalon S, Tarkiainen J, Garreau L, Hall H, Emond P, Vercouillie J, et al. (January 2003). “Pharmacological characterization of N,N-dimethyl-2-(2-amino-4-methylphenyl thio)benzylamine as a ligand of the serotonin transporter with high affinity and selectivity”. The Journal of Pharmacology and Experimental Therapeutics. 304 (1): 81–87. doi:10.1124/jpet.102.042226. PMID 12490578.
  2. ^ Tarkiainen J, Vercouillie J, Emond P, Sandell J, hiltunen J, Frangin Y, et al. (2001). “Carbon-11 labelling of MADAM in two different positions: a highly selective PET radioligand for the serotonin transporter”. Journal of Labelled Compounds and Radiopharmaceuticals. 44 (14): 1013–1023. doi:10.1002/jlcr.523. ISSN 0362-4803.
  3. ^ Larsen AK, Brennum LT, Egebjerg J, Sánchez C, Halldin C, Andersen PH (March 2004). “Selectivity of (3)H-MADAM binding to 5-hydroxytryptamine transporters in vitro and in vivo in mice; correlation with behavioural effects”. British Journal of Pharmacology. 141 (6): 1015–1023. doi:10.1038/sj.bjp.0705693. PMC 1574267. PMID 14993096.
  4. ^ Halldin C, Lundberg J, Sóvágó J, Gulyás B, Guilloteau D, Vercouillie J, et al. (December 2005). “[(11)C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PET”. Synapse. 58 (3). New York, N.Y.: 173–183. doi:10.1002/syn.20189. PMID 16138320.
  5. ^ Lundberg J, Odano I, Olsson H, Halldin C, Farde L (September 2005). “Quantification of 11C-MADAM binding to the serotonin transporter in the human brain”. Journal of Nuclear Medicine. 46 (9): 1505–1515. PMID 16157534.
  6. ^ Guilloteau D, Tarkiainen J, Garreau L, Vercouillie J, Emond P, Besnard JC, et al. (August 2001). “Pharmacological characterization of N, N-dimethyl-2 (2-amino-4-methylphenylthio) benzylamine or MADAM as a radioligand of the serotonin transporter with high affinity and selectivity”. European Journal of Nuclear Medicine. 28 (8): 997.
  7. ^ Chalon S, Tarkiainen J, Garreau L, Hall H, Emond P, Vercouillie J, et al. (July 2002). “N,N-dimethyl-2-(2-amino-4-methylphenylthio) benzylamine or MADAM is a serotonin transporter ligand with high affinity and specificity: in vitro characterization”. NeuroImage. 16 (3): S18.